Site Search:

Home

Outsourcing Asia

Outsourcing Showcase

RFQ/Showcase-Subscribe

BioChannels

Reports Store

Investor/Venture Capital

Directory

Events

News

Career

Industry Publications

Tools & Resources

CanBiotech Outsourcing

Clinical Trials   Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease PR Newswire   3 Mar 2010 CREST Clinical Trial Results Find That Carotid Artery Stenting is as Safe and Effective as Conventional Surgery PR Newswire   3 Mar 2010 TechniScan Launches 3-D Breast Ultrasound Clinical Study in Freiburg University PR Newswire   3 Mar 2010 Cardio3 BioSciences Announces Promising Pre-Clinical Data for Proprietary C-Cath(R) Catheter PR Newswire   3 Mar 2010 Celsion Plans to Launch Phase II Program to Study ThermoDox(R) in Combination with RFA for Colorectal Liver Metastases PR Newswire   3 Mar 2010  Clinical: Phase I/II/III   Celsion Plans to Launch Phase II Program to Study ThermoDox(R) in Combination with RFA for Colorectal Liver Metastases PR Newswire   3 Mar 2010 Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease PR Newswire   3 Mar 2010 Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer PR Newswire   25 Feb 2010 VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With Diabetic Macular Edema PR Newswire   22 Feb 2010 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Combination Study of MM-121 and Tarceva(R) in Patients with Non-Small Cell Lung Cancer PR Newswire   22 Feb 2010

Clinical: Approvals   FDA Approves NerPharMa to Manufacture Cell Therapeutics' Drug Pixantrone PR Newswire   8 Mar 2010 ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM) PR Newswire   8 Mar 2010 BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million PR Newswire   3 Mar 2010 Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease PR Newswire   26 Feb 2010 Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure PR Newswire   25 Feb 2010

Participating on CanBiotech's Networks
Using the Site Privacy & Security Statement

Service Provider Spotlight/Showcase Guide
Advertise with us Directory Guide & Access Policy
News Postings Event Postings CanBiotech Newsletters

© 2000-2010 CanBiotech™ Inc.